Monday, April 30, 2007

Citigroup (C) Execs Fear Activist Funds

According to reports from FT.com this morning, top executives at Citigroup (NYSE: C) are worried the company could become the target of activist hedge funds that could press for a break-up of the company. Activist could also push to force out CEO Chuck Prince.

The report said fears have been heightened following a successful push from The Children's Investment Fund to force a break up of ABN Amro (NYSE: ABN), which has led to a bidding war for the Dutch bank.

Many think Citigroup is too big to become an activist target.

Looking through the list of holders there are no "usual suspects" of the activist hedge fund variety that hold any meaningful position. In the top 25 holders there are two, Morgan Stanley and T.Rowe Price, that have been involved in activist situations recently. Neither are activist funds, but have tried to push for changes. Morgan was looking for changes to the share structure at the New York Times (NYSE: NYT) and T.Rowe Price has opposed mergers at Diversa (Nasdaq: DVSA) and Laureate Education (Nasdaq: LAUR). Morgan Stanley owns a 1.34% stake in Citigroup and T.Rowe Price owns a 0.7% stake.

The top five holders of Citigroup are Barclays (4.44%), Price Alwalled Bin Talal (4.44%), Capital Research and Management (4.41%), AXA (3.49%) and State Street (3.1%).

Ex-CEO of Citigroup Sanford Weill owns 16.6 million shares or 0.34% of Citigroup.

Looking at the ABN situation, The Children's Investment Master Fund only held about 1% of ABN AMRO when they successfully pushed for a break-up at the bank.

Another scenario where a relatively small holder successfully pushed for changes at a large company involved Home Depot (NYSE: HD). Relational Investors owned just 0.64% of Home Depot when they successufully pushed for changes at the home improvement giant, including the ousting of CEO Bob Nardelli. Relational Investors was also awarded a board seat at Home Depot.

History has shown that it does not take an enormous stake in a company to successfully push for changes especially if investor sentiment is with the activist, which with Citigroup appears to be the case. Citigroup executives might be right to fear activists.

Labels: ,

O.S.S. Capital Discloses 5% Stake in Hexcel (HXL); Concerned About Underperformance, Wants Banker Hired

In a 13D filing after the close Friday on Hexcel Corp. (NYSE: HXL), O.S.S. Capital Management LP disclosed a 5.1% stake (4.8M shares) in the company and disclosed two letters sent to the company discussing their concern that the Company was under-performing.

On March 9, the firm sent a letter to the Company expressing its concern regarding the Company's operating performance relative to its peers and with the management's lack of concern regarding the gap in performance. The firm also noted that a member of the Company's Board of Directors was stepping down and suggested a candidate for his replacement.

On April 9, the Company's CEO visited OSS's offices.

On April 26, the firm sent a letter reiterating its concern that the Company was under performing. The firm requested a committee of independent directors be formed and that the committee retain an independent investment bank to advise as to how shareholder value could be best maximized.

Copy of March 9th Letter:

Dear David:

As a long-term shareholder of Hexcel, we are concerned about the company's operating performance relative to its peers and with management's apparent lack of concern about this matter. Although Hexcel's operating margin expansion from7% in 2002 to 10% in 2006 seems respectable, a different picture emerges when this performance is benchmarked against other industry competitors.

Specifically, Cytec Industries' Engineered Materials segment generated operating margins of 18%, and the difference is even more pronounced at Toray Industries.For the nine months ended December 2006, Toray's Composite Materials segment had operating margins of over 25%. In the past, you have said that the margin discrepancy between Hexcel and its competitors was due to corporate allocation nuances and/or product-mix issues. However, after conducting an extensive industry analysis, including talking to public and private competitors, we believe the lower margins are due to mismanagement of the company.

Had Hexcel achieved operating margins of only 17% on its 2006 revenues, the company would have earned an additional $78 million in operating income.Applying the current 17x multiple of enterprise value to operating income, this difference would result in a value increase of more than one billion dollars.Therefore, at current margins of lo%, shareholders are "forgoing" over $14.00per share.

You do not seem concerned about this gap. Although management has outlined a future target of mid-teens operating margins, by the time the company achieves this goal it will still be under performing its competition. The management and the Board must develop a plan of action for closing the gap; if you are unwilling or unable to do this, then it is incumbent on the Board to seek strategic alternatives and/or sell to a buyer that can run the company more profitably.

On a final note, it is our understanding that Mr. Martin L. Solomon will be stepping down as a Director of Hexcel in May. We have a candidate in mind who would be a valuable addition to the Board and would like to submit him for your consideration.

We look forward to your response.

Sincerely,
Oscar S. Schafer

Copy of April 26 Letter:

Dear David:

Thank you for visiting our office on April 9th. The answers we received reinforced our views outlined in our letter dated March 9, 2007 (which is attached) that (1) Hexcel is under-earning, (2) management is not addressing the shortfall in earnings, and (3) the shareholders are suffering from this situation. We think that Hexcel would benefit from an independent review of its prospects and strategy with a view toward taking action to maximize shareholder value. To accomplish this, we request a committee of independent directors be formed and that the committee retain an independent investment bank to advise as to how shareholder value can best be maximized.

We are filing a schedule 13D with the Securities and Exchange Commission disclosing our ownership of 4,810,900 shares of Hexcel stock. This letter and our earlier letter will be attached to that filing.

We look forward to the Board's response.

Sincerely,

Oscar S. Schafer

Labels: , , ,

Friday, April 27, 2007

Sandell Gets Its Way With InfoSpace (INSP), But Shares Lag on Guidance

Sandell Asset Management scored a bitter-sweet victory related to its activism in InfoSpace, Inc. (NASDAQ: INSP).

After the close, InfoSpace and Sandell announced an agreement that will avoid a proxy contest. As part of the agreement, InfoSpace incorporated several of Sandell's suggestions including: Sandell's Nick Graziano being appointed to the Board; the Company announced a $6.30/share special dividend; the Board will reauthorize its $100 million share repurchase program; and Mr. Graziano will join a committee to evaluate the Company's strategy to close what the Company believes is a gap between the current price of the Company's shares and their intrinsic value. Also as part of the settlement, Sandell has agreed to abide by certain standstill provisions through February 2008.
InfoSpace also announced Q1 results and said it is expecting a GAAP net loss for the year. Shares of are off about 5.5% today.

Labels: , ,

Thursday, April 26, 2007

3V Capital Seeks Representation on Universal Power Group (UPG) Board, Disappointed in Stock Performance

In a 13D filing this morning on Universal Power Group Inc. (AMEX: UPG), 12.6% holder 3V Capital Management disclosed a letter which, among other things, requested representation on the Board of Directors of the Company and requested a meeting with the Board of Directors to discuss their views with respect to creating shareholder value and improving the market's impression of the intrinsic value of the Company's business.

In the letter the firm said, "Just as you must be, we are concerned about the performance of UPG's stock which has fallen 33.6% since the IPO last December based upon yesterday's closing price of $4.65 per share. We believe that the stock is grossly undervalued at this price. It is obvious the market does not ascribe a value to the Company, for whatever reason, which we believe to be consistent with the intrinsic value of the business. We believe our interests and those of the Board are aligned: to create shareholder value in the most effective and expeditious way and do what is possible to ensure the market is reflecting the fair value of the business as consistently and often as feasible. Accordingly, as the largest unaffiliated shareholder with 21% of the public float, we would like the opportunity to express our ideas and views on way to enhance shareholder value, and to express such views with representation on the Board."

A Copy of the Letter:

Members of the Board:

3V Capital Management is the investment advisor to funds which own 628,700shares or 12.6% of the common stock of Universal Power Group, Inc. ("UPG" orthe "Company"). As such, we are the largest non-affiliate shareholder, the second largest overall. First and foremost, we commend the management of UPG for building a great business with a world class Board, unique products and strong relationships with key customers. We recognize the challenges of managing a business which has been growing as fast as UPG. We also appreciate UPG's commitment to sound corporate governance as expressed by the "Corporate Governance Guidelines" published on the Company's website.

Just as you must be, we are concerned about the performance of UPG's stock which has fallen 33.6% since the IPO last December based upon yesterday's closing price of $4.65 per share. We believe that the stock is grossly undervalued at this price. It is obvious the market does not ascribe a value to the Company, for whatever reason, which we believe to be consistent with the intrinsic value of the business. We believe our interests and those of the Board are aligned: to create shareholder value in the most effective and expeditious way and do what is possible to ensure the market is reflecting the fair value of the business as consistently and often as feasible. Accordingly,as the largest unaffiliated shareholder with 21% of the public float, we would like the opportunity to express our ideas and views on ways to enhance shareholder value, and to express such views with representation on the Board.

We have an excellent relationship with senior management. Our intent is to work constructively and consensually with your executive management team and the entire Board to help refine and better communicate your business strategy and operating plan to the investor community. Our investment portfolio and client network provides us with considerable access to and strong relationships with the institutional investor and analyst community in ways which can be quite beneficial to you and all of UPG's shareholders. Moreover, while we are not being critical per se of UPG's business model, we would like to demonstrate to you that we have the resources to help expedite the achievement of management's financial goals, improve profitability and drive the performance of UPG's stock.

We trust that the Board would welcome our voice and the shareholder perspective it would bring to the Board's inner deliberations. Our suggestion is in the best interest of all shareholders because it provides significant outside shareholder representation on the Board.

We wish only to be constructive in evaluating matters which bear on the appropriate reflection of the value of this business in the stock market and would like to meet with the directors at their convenience.

Very truly yours,
David D.R. Bullock
Managing Director

Labels: , ,

Breeden Scores Nice Win in Applebee's (APPB) Fight

Former SEC-Cheif turned activist investors, Richard Breeden, scored a nice win today on Applebee's (Nasdaq: APPB). Not only did Breeden and another Breeden nominee Laurence Harris get on the board, but the company announced that its strategic reivew process has yielded several non-binding, preliminary proposals to acquire the company.

Breeden paid about $19.90 per share for his 3.9 million share stake. Today the stock is trading at $26.88. That's a 35% gain!

Other stocks in Breeden portfolio are Alexander & Baldwin Inc. (Nasdaq: ALEX), Bausch & Lomb Inc. (NYSE: BOL), H&R Block, Inc. (NYSE: HRB), Helmerich & Payne (NYSE: HP), Steris Corp. (NYSE: STE), Walter Industries Inc. (NYSE: WLT) and Warnaco Group (Nasdaq: WRNC).

Labels: , , , , , , , , , , , , , , , ,

Wednesday, April 25, 2007

Schultze Asset Opposes MAIR HOLDINGS (MAIR) Acquisition Plans, Wants Big Sky Subsidiary Sold

In a 13D filing on MAIR HOLDINGS (Nasdaq: MAIR), Schultze Asset Management disclosed a 5.9% stake in the company and said they are disappointed that the Company may be planning to pursue acquisitions that may be outside of the airline industry using shareholders' cash. The firm believes the board's and Company's best course of action would be to distribute any and all cash remaining after the reorganization transaction to shareholders as soon as possible in a tax-efficient manner.

Separately, the firm believes that the Company should initiate efforts to sell its Big Sky subsidiary as soon as possible by retaining a nationally recognized investment bank to do so.
The firm believes that the shares are substantially undervalued based on the amount of cash that would be distributed to shareholders in the event the board implements its suggestions.
The firm said it may make proposals to the board, seek to change the composition of, or seek representation on, the board, all with the underlying purpose of increasing shareholder value. In addition, the Reporting Persons may acquire additional shares (i) for investment purposes, (ii) to change or influence the control of the Company, and/or (iii) with a view toward a possible acquisition of the Company.

Labels: , ,

Tuesday, April 24, 2007

Millenco Disclosed a Number of New 5%+ Positions: EAR, VSTA, ORCH

Millenco disclosed a number of new 5%+ positions in various 13D filings after the close yesterday.
HearUSA Inc. (AMEX: EAR) 5.2% (1,625,343 shares), up from 1,060,235 at 12/31/06
VistaCare Inc. (Nasdaq: VSTA) 7.1% (1,194,092), up from 513,245 at 12/31/06

Orchid Cellmark Inc. (Nasdaq: ORCH) 7.2% (2,108,769 shares), no stake at 12/31/06

The firm did not disclosed an plans related to issues, but reserved the right to raise or lower their positions and communicate with third parties or with management of the various companies.

Labels: , , , , , ,

Recommended Reading for Emmis Comm (EMMS) Board "John Bogle’s The Battle for the Soul of Capitalism"

In an amended 13D filing yesterday afternoon on Emmis Communications (Nasdaq: EMMS), 8.4% holder Martin Capital Management disclosed a letter sent to the company's board of directors discussing recent rumors involving the potential sale of WQCD.

The firm said, "Recent scuttlebutt, made more tangible by a recent sell-side research note and the uptick in Emmis’ market price, has reached all the way to the hinterlands of Elkhart, Indiana. We discount rumors and in this instance are bringing the current one to your attention as a courtesy from an interested large long-term shareholder so that the Company might take whatever action may be necessary in accordance with SEC rules and regulations. For your information, the rumors involve the potential sale of WQCD. Parenthetically, if the rumored sale price of $200–250 million is in the “ballpark,” the Company would certainly have an opportunity to monetize valuable assets that are not contributing to cash flow in appropriate proportion to their private sale value. Based on information the Company has provided, KMVN, WKQX, and WLUP might qualify as well. The Board is no doubt aware that such a strategy would unlock considerable value that would better reflect the intrinsic worth of the Company. Indeed, it would not surprise us if such future possibilities may have played a role in both the initiation of Mr. Smulyan’s “going private” offer last spring and the Board’s determination that his offer was inadequate. We were encouraged when the Board began to flex its fiduciary muscles and remain hopeful that the Board will stay the course, no matter what kind of chicanery it might encounter in the weeks or months ahead. We have long felt that there is more value in Emmis than what the market price would suggest. Whether the CEO, ideally with the encouragement of a Board that has been far too passive for far too long, will 1) take the strategic steps to realize that value and 2) share it equitably once realized remains the open question. Until shareholders receive an honest answer to that question the Emmis dollar will continue to trade for $.50."



There was another part to Martin Capital's letter written just before the recent rise in the stock price and the rumors that followed. Martin Capital said it wrote the letter as the one-year anniversary of their Emmis 13D filing and Berkshire Hathaway's annual meeting nears.

Martin Capital compares corporate governance at Emmis with Berkshire Hathaway. They said, "Martin Capital Management has positions in both companies, one we own with deep regrets and fiduciary shame for our stupidity (EMMS) and the other where integrity is so deeply rooted that even investor foolishness will not be exploited by the keeper of the castle (Berkshire)."


Martin Capital said with the letter they encloused a gift on behalf of all of the disenfranchised Class A shareholders - the book "John Bogle’s The Battle for the Soul of Capitalism"

Martin Capital closed the letter saying, "Edmund Burke, the 17th century statesman and philosopher most remembered prophetically for his support of the American colonies in the dispute with King George III and Great Britain that led to the American Revolution, speaks to the dilemma that you, the Board of Directors, those entrusted with protecting the public’s interest in the representative democracy at Emmis, must face. Does the following quotation not characterize the Emmis Chairman and CEO? “Those who have been once intoxicated with power, and have derived any kind of emolument [compensation] from it, even though but for one year, never can willingly abandon it. They may be distressed in the midst of all their power; but they will never look to anything but power for their relief." Martin then asks, "Are you made of the stuff of our forefathers? Are you willing to be part of the revolution to reestablish the soul of capitalism?"

A Copy of the Letter:

Dear Mr. Smulyan:

Recent scuttlebutt, made more tangible by a recent sell-side research note and the uptick in Emmis’ market price, has reached all the way to the hinterlands of Elkhart, Indiana. We discount rumors and in this instance are bringing the current one to your attention as a courtesy from an interested large long-term shareholder so that the Company might take whatever action may be necessary in accordance with SEC rules and regulations. For your information, the rumors involve the potential sale of WQCD. Parenthetically, if the rumored sale price of $200–250 million is in the “ballpark,” the Company would certainly have an opportunity to monetize valuable assets that are not contributing to cash flow in appropriate proportion to their private sale value. Based on information the Company has provided, KMVN, WKQX, and WLUP might qualify as well. The Board is no doubt aware that such a strategy would unlock considerable value that would better reflect the intrinsic worth of the Company. Indeed, it would not surprise us if such future possibilities may have played a role in both the initiation of Mr. Smulyan’s “going private” offer last spring and the Board’s determination that his offer was inadequate. We were encouraged when the Board began to flex its fiduciary muscles and remain hopeful that the Board will stay the course, no matter what kind of chicanery it might encounter in the weeks or months ahead. We have long felt that there is more value in Emmis than what the market price would suggest. Whether the CEO, ideally with the encouragement of a Board that has been far too passive for far too long, will 1) take the strategic steps to realize that value and 2) share it equitably once realized remains the open question. Until shareholders receive an honest answer to that question the Emmis dollar will continue to trade for $.50.

The following letter was written just before the recent rise in the stock price and the rumors that followed. Because of its long-term relevance and our reluctance to take our eye off the investment ball because of the ambient noise, it remains as the substance of this communiqué with you.

With the one-year anniversary of our Emmis 13D filing just over a month away and the annual trip to the “ethicenter” of American capitalism coming up soon (Berkshire Hathaway’s annual meeting, Omaha, May 5), the arresting juxtaposition of two extremes in corporate governance prompted this latest missive. Martin Capital Management has positions in both companies, one we own with deep regrets and fiduciary shame for our stupidity and the other where integrity is so deeply rooted that even investor foolishness will not be exploited by the keeper of the castle.

This letter has elements and themes in common with others sent to you individually or as a group, as well as articles in various and sundry publications available on our website, and at least one aspect that is different. Among the enclosures herewith you’ll find a gift from me on behalf of all of the disenfranchised Class A shareholders: John Bogle’s The Battle for the Soul of Capitalism. Bogle, 77, painfully jobless at age 45 toward the end of the cruel 1973–1974 bear market, mustered the will to found what has become the $1.1 trillion in assets Vanguard Group, the ethical standard bearer for the mutual fund industry. Even at Vanguard, a mutual company, he again felt the pain of being vulnerable to shifting sentiments. In refreshing contrast to the “turf protection,” the breeding ground for greed and avarice so prevalent in corporate America these days, Bogle’s irrepressible character has sustained him as the ultimate shareholder advocate whose words reconcile in sweet harmony with his actions.

Like it or not, you are thrust into a minor role in an unfolding drama that may determine the fate of capitalism in which Emmis, although a bit player, is yet to be counted as either just or unjust. You could be a big player if you stand up for what’s true and right. Only you can write your own epitaph. If you’ve lost sight of what it means to be a fiduciary, why directors’ fees are not without obligation, or if you need someone to explain the gravity of the bigger issue at stake, the words of Jack Bogle, if taken to heart, will help reset your fiduciary’s compass to true North.

Given the size of our clients’ and our 8% plus stake in Emmis, well purchased as investors in the open market but far too long ago, the minuscule investment in the books may provide a whopping return if you take the time to contemplate the significance of Bogle’s clear-cut warnings and insights as to what might be your role in the battle for the soul of capitalism and then take the actions he proposes. Should the book’s contents touch a socially responsive nerve, or provoke a twinge of consciousness about just what might be the high road as you perform your fiduciary duties and responsibilities as an Emmis director, the much-maligned Emmis principals, who, need I remind you, own 86.3% of the Company, will be the ultimate co-beneficiaries. The other potential beneficiaries are, strangely enough, you, the members of the Board of Directors, who perhaps for the first time since joining Emmis can justifiably walk tall if you heed Bogle’s advice. While the entire book is more than worthy of your attention, Parts I and II, covering a mere 117 pages, are most relevant to the study in contrasts to which I referred above.

Intentionally free of the manifold conflicts of interest that hobble many of our contemporaries, I will continue to speak out against the injustices perpetrated against the majority shareholders by the Emmis CEO and the Board of Directors which, much to the satisfaction of the silenced majority, has recently begun to demonstrate some honest-to-goodness moxie. While there are issues of far greater import addressed in the enclosed Martin Capital Management 2006 Annual Report, ongoing references to Emmis can be found on pages 18–20, including the footnote on page 20.

Depending on inferences one might glean from what may be mandatory abstentions for Emmis shares registered in street name, it is quite possible that the only significant “no” vote for our proxy proposal calling for recapitalization of Emmis from the inescapable tyranny of the Class B super voting majority share structure was from the Emperor himself who, perhaps feeling a little insecure, dictated that he alone should be above the constraints of accountability. Certainly no informed, uncompromised, and self-respecting shareholder would vote for retaining dictatorial powers in the hands of one whose exercise of those powers may, and no doubt already has, lead inexorably to the slide down the slippery slope of self-aggrandizement.

The $4 special dividend paid in November is but the latest in questionable capital allocation decisions, which remains our single biggest concern about strategic decision-making at Emmis. The only positive aspect to the distribution is that it was equitable: Mr. Smulyan found himself in the unlikely position of being at parity with the majority owners when it came to distributing corporate assets. Even the motives behind the dividend are suspect in that the action was out of character: to wit, Mr. Smulyan’s earlier initiatives, such as the proposed going private transaction in 2006, and his rhetoric subsequently have openly and brashly betrayed his intent to enrich himself at the expense of the majority shareholders. At this time we can only speculate about the true motives behind the dividend.

Edmund Burke, the 17th century statesman and philosopher most remembered prophetically for his support of the American colonies in the dispute with King George III and Great Britain that led to the American Revolution, speaks to the dilemma that you, the Board of Directors, those entrusted with protecting the public’s interest in the representative democracy at Emmis, must face. Does the following quotation not characterize the Emmis Chairman and CEO? “Those who have been once intoxicated with power, and have derived any kind of emolument [compensation] from it, even though but for one year, never can willingly abandon it. They may be distressed in the midst of all their power; but they will never look to anything but power for their relief.”

Are you made of the stuff of our forefathers? Are you willing to be part of the revolution to reestablish the soul of capitalism?

Labels: , ,

Loeb's Third Point LLC Discloses 8.1% Passive Stake in ATP Oil & Gas (ATPG)

In a 13G filing after the close on ATP Oil & Gas Corp. (Nasdaq: ATPG), Dan Loeb's Third Point LLC disclosed an 8.1% stake (2.45 million shares) in the company. The firm did not show a stake in ATPG for the quarter ended December 31, 2006.

While the 13G filing indicates a passive stake, Loeb is a known activist investor.

ATP Oil & Gas is an international offshore oil and gas development and production company with operations in the Gulf of Mexico and the North Sea.

Shares of ATP Oil & Gas are up 6% in early trading.

Labels: , , ,

Monday, April 23, 2007

Sun Capital Securities Raises Stake in Nautilus (NLS) to 6.6%

In an amended 13D filing on Nautilus, Inc. (NYSE: NLS), Sun Capital Securities disclosed a 6.6% stake (2.1 million shares) in the Company. This is up from the 1.71 million share stake the firm disclosed for the quarter ended December 31, 2006.

The firm made no changes to Item 4 of the filing, which in the original filing said they have no present plans or proposals that relate to or that would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D.

Labels: ,

Dan Loeb: Hedge Fund and Buyout King?

In an amended 13D filing on Flow International Corp. (NASDAQ: FLOW), 13.6% shareholder Dan Loeb's Third Point LLC said "we have decided that we would be prepared to make an offer, on behalf of the Third Point funds, for the purchase of the entire Company. However, in order to formulate a proposal that would maximize value for shareholders, we would need access to additional information regarding the Company and would need a manager capable of running the Company after we acquire it."

In the letter, Loeb requested that the Board waive the restrictive provisions of retiring CEO Stephen Light's employment agreement with the Company so that Mr. Light would be in a position, if he so chose, to work with them to develop a business plan and valuation upon which their bid could be based.

A Copy of the Letter:

Dear Flow Directors:

We have been considering the response of Flow International Corporation("Flow" or "the Company") to our last letter, as expressed in the Company's press release of April 6. In that release, the Board assured shareholders that it is "devoted to optimizing shareholder value" and indicated its intention to formulate a "plan for how best to optimize shareholder interests." As you know,we have expressed the view that, in light of the pending retirement of Stephen Light as CEO, and the costs of public ownership, the best way to achieve that objective is for the Company to be sold.

Upon further review, we have decided that we would be prepared to make an offer, on behalf of the Third Point funds, for the purchase of the entire Company. However, in order to formulate a proposal that would maximize value for shareholders, we would need access to additional information regarding the Company and would need a manager capable of running the Company after we acquire it. Given our tremendous confidence in Mr. Light, which we've expressed more than once, we would like to see if we could work with him to develop a business plan for a privately held Flow. Accordingly, we are asking the Board to waive the restrictive provisions of Mr. Light's employment agreement and to authorize him to engage in discussions with us, if he so chooses, so we can develop a business plan and valuation upon which our bid can be based. To be productive,we would anticipate that those discussions would require the sharing of confidential information, and would be prepared to enter into an appropriate agreement to protect that information from misuse.

As you aptly said in your April 6th press release: "[i]t would be a breach of [your] fiduciary responsibility to [your] shareholders for the Board to proceed in any one manner without a thoughtful evaluation of the business, its potential, the state of the marketplace and the Company's options." We believe that we can present to the Board an attractive option that the Board can weig hagainst the other possibilities, and we believe the Board would be remiss not to avail itself of this opportunity.

Please let us know promptly whether you are prepared to permit such a process in order to create an opportunity for the Company to maximize shareholder value.

Sincerely,

Daniel S. Loeb

Third Point LLC

Past Reports on Loeb's FLOW postion

Labels: , , ,

Millenco Raises Stake in ArQule (ARQL) to 6.3%

In a 13D filing Friday afternoon on ArQule Inc. (Nasdaq: ARQL), Millenco disclosed a 6.3% stake (2,250,324 shares) in the company. This is up from the 1,359,524 share stake the firm held for the quarter ended December 31, 2006.

In a pretty standard disclosure, Millenco said from time to time they may hold discussions with third parties or with management with respect to potential changes in the operations, management or capital structure of such companies as a means of enhancing shareholder value. The firm does not have any present plans or proposals that relate to or would result in any of the actions required to be described in Item 4 of Schedule 13D.

Labels: , ,

French Raider Bollore Discloses 6.4% Stake in Harris Interactive (HPOL)

In a 13D filing after the close Friday on Harris Interactive Inc. (Nasdaq: HPOL), Vincent Bolloré disclosed a 6.4% stake (3.4 million shares) in the company.

Bolloré indirectly controls Financière de Sainte-Marine (FdSM). This investment is part of the strategy of the Bolloré Group in the media and communication industry.

Bolloré and FdSM do not currently intend to seek control of the Issuer, although Mr. Bolloré and FdSM reserve the possibility to change their position in the future.


Bolloré is a well known corporate raider in France.

Labels: , ,

Friday, April 20, 2007

13Gs - Ziff Asset Shows 8.8% Stake in Beazer (BZH); Citadel Raises Stake in AirTran (AAI) to 5.6%

Slow day so far for 13Ds, but here are a couple of interesting 13G filings (passive investors):

In a 13G filing after the close on Beazer Homes USA Inc. (NYSE: BZH), Ziff Asset Management disclosed an 8.8% stake (3.47 million share) in the homebuilder. Ziff Asset Management is affiliated with Ziff Brothers Investments L.L.C., which is run by the heirs to the Ziff-Davis publishing empire.
In a 13G filing this morning on AirTran Holdings, Inc. (NYSE: AAI), Citadel LP disclosed a 5.6% stake (5,104,092 shares) in the company. This is up from the 767,747 share stake the firm held for the quarter ended December 31, 2006.AirTran is a leading low-fare airline. AirTran has unsuccessfully been trying to buy rival Midwest Air Group (AMEX: MEH). Started by market-guru Kenneth Griffin in his Harvard dorm room in 1987, Citadel has become one of the world's largest hedge funds.

Labels: , , , , , ,

Thursday, April 19, 2007

Large Griffin Land & Nurseries (GRIF) Holder Gabelli Said Company Should Have Bought Back More Shares

In an amended 13D filing on Griffin Land & Nurseries Inc. (Nasdaq: GRIF), 31.1% holder Gabelli discloses a letter to the CEO. Gabelli notes "the share creep" since 2001, saying he realizes its due to options, but said at a minimum the company should have bought enough shares back to offset the dilution. Gabelli notes that the stock is materially undervalued. Gabelli also said, "I look forward to discussing the notion of harvesting our real estate assets."

A Copy of the Letter:

Mr. Frederick M. Danziger

President and Chief Executive Officer

Griffin Land & Nurseries, Inc.

One Rockefeller Plaza

New York, NY 10020

Dear Mike:

Trust all is well. I just read your 2006 Annual Report.

Enclosed is a grid that shows "the share creep" since '01.

We realize it's due to options exercised - but at a minimum you should have bought enough shares back to offset the dilution.

More importantly, the value of your enterprise is materially above where your stock is selling so we remain somewhat miffed at the glacial speed of your share repurchase.

On another note, I look forward to discussing the notion of harvesting our real estate assets.

Trust you understand.

Sincerely,

Mario J. Gabelli

TABLE

Labels: , ,

eSpeed (ESPD) Comments on Tullett Proposal and Recent Shareholder Statements

eSpeed, Inc. (NASDAQ: ESPD) commented on recent statements and proposals made by one of eSpeed's competitors and by certain shareholders in Schedule 13D filings in recent weeks.

The Company said on April 19th they sent a letter to Terry Smith of Tullett Prebon plc stating that the Board of Directors has been informed by its controlling stockholder, Cantor Fitzgerald, L.P., that it is not interested in selling its controlling interest in the Company to Tullett, in terminating its arrangements with eSpeed on the terms proposed by Tullett in its recent letters, or in proposing alternative terms to Tullett. The Company is not in a position to pursue Tullett's acquisition proposal because such a proposal cannot be consummated without the consent of our controlling stockholder.
Yesterday, Tullett Prebon disclosed its $12 offer for eSpeed.
Activist shareholders, Chapman Capital and WC Capital have been pushing for a sale of the company. Chapman also wants members of eSpeed's board replaced, an independent auditor to review the Joint Services Agreement and the conversion of all Class B common shares into Class A common stock

Labels: , , ,

Wednesday, April 18, 2007

eSpeed (ESPD) Holder WC Capital Wants Evaluation of Tullet Bid, Encourages Cantor to Make Bid

In a press release on eSpeed Inc. (Nasdaq: ESPD), 6.4% holder WC Capital called for an independent evaluation of Tullet Prebon's $12 bid for the Company.

Aaron Braun, the manager of WC Capital, said, "We view the Tullet Prebon bid as extremely attractive and deserves to be considered by the independent directors of eSpeed. Should Cantor Fitzgerald L.P. decide to match this or any potential future offer, we would welcome that development."
WC Captial said the $12 bid is at the low end of the $12 to $16 valuation range for eSpeed.
Shares of eSpeed are up about 10% today to $10.58.

Labels: , ,

Loeb Reiterates Call for PDLI's CEO's Head; Says Company Should Follow MEDI to the Auction Block

Large PDL BioPharma (Nasdaq: PDLI) shareholder Third Point LLC, run by Daniel Loeb, confirmed what they called a "very disappointing" response to their recent requests and reiterated its demand that CEO Mark McDade step down, citing his misteps including unnecessary spending on the Company's corporate headquarters (Loeb called it the Taj Mahal) as well as wasteful R&D and SG&A spending.

Third Point requested that the Company founder and board member Laurence Korn be immediately installed as acting chief executive officer and chairman.



ThirdPoint said PDLI's Board should act in a similar fashion to MedImmune's (Nasdaq: MEDI) board, which announced last week that they engaged Goldman Sachs to explore a sale of the Company.

Third Point ended saying, "In sum, we ask the Board to look past personal loyalty to Mr. McDade and think objectively about his performance and about the Board's duty to shareholders. We are confident that you will come to the conclusion that Mr. McDade must go and that an investment bank should be engaged to explore strategic alternatives expeditiously."

Press Release from Third Point

Labels: , , ,

Tullett Bids $12 for eSpeed (ESPD), Chapman Recommends Kozlowski or Ebbers As Ethics Officer

Earlier, Tullett Prebon plc confirmed that it has made an approach to eSpeed, Inc. (Nasdaq: ESPD) in relation to a possible acquisition by Tullett Prebon of eSpeed at a price of $12 per eSpeed Class A Common Share in cash.

Tullett said eSpeed referred this proposal to Cantor and has informed them that Cantor is not interested in selling its controlling interest on the terms proposed.

eSpeed has been an activist target of Chapman Capital, which today demanded the replacement of eSpeed Directors Albert Weis, John Dalton, Barry Sloane & Barry Gosin. Chapman Capital also reiterated its demands that the Board immediately retain an independent auditor to review the Joint Services Agreement, compel the conversion of all Class B common shares into Class A common stock, and engage an investment bank to maximize shareholder value via an auction of the Company.

Robert L. Chapman, Jr., Managing Member of Chapman Capital, said, "Chief Executive Howard Lutnick's three-kingdom reign over Cantor Fitzgerald, eSpeed and BGC Partners appears so infested with potential conflicts of interest and incestuous inter-company transactions that a completely new set of corporate governors may be required to exterminate any vermin from eSpeed's board room."

Chapman also mockingly said, "Following eSpeed's April 12th arguably belated decision to hire a 'Chief Ethics Officer,' I propose that either Dennis Kozlowski or Bernie Ebbers be considered to fill the position once they have been discharged from their respective prison cells."

Chapman's Press Release

Labels: , , , ,

Children's Looking for a Ride on CSX's Railroad

The Children's Investment Fund filed under Hart-Scott-Rodino to acquire more than $500 million of CSX Corp. (NYSE: CSX) stock.

From CSX's 10-Q filing: On March 15, 2007, CSX received notice from The Children's Investment Fund Management (U.K.) LLP that it had made a filing under the Hart-Scott-Rodino Antitrust Improvements Act to acquire more than $500 million of CSX stock. That firm has also advised CSX that it currently holds a significant economic position through common stock ownership and derivative contracts tied to the value of CSX stock. The Company is voluntarily furnishing this information.

If you remember, UK-based Children's Investment Fund was instrumental in getting ABN AMRO Holding N.V. (NYSE: ABN) to the auction block.

Recently, Warren Buffett disclosed a 10.9% stake in Burlington Northern Santa Fe Corp. (NYSE: BNI) and is said to be accumulating stakes in two other North American railroads yet to be disclosed.

Labels: , , , , ,

Tuesday, April 17, 2007

Pemco Aviation (PAGI) Chairman Offers to Acquire Co. Subsidiary for $30 Million

In an amended 13D filing on Pemco Aviation Group Inc. (Nasdaq: PAGI), Chairman and 26.6% holder Michael Tennenbaum delivered to Pemco an offer to purchase all of the outstanding capital stock of Pemco World Air Services, Inc., a wholly-owned subsidiary of Pemco.

In the letter Tennenbaum said, "In order to assure that Pemco Aviation Group, Inc. is not forced into accepting a less than appropriate bid to acquire PWAS due to financing needs, I hereby agree, at your option, (1) to purchase all of the outstanding capital stock of PWAS for $30 million in cash, or (2) to provide or cause to be provided to Pemco financing on commercially reasonable terms in an amount sufficient to refinance all of Pemco’s then current debt such that no principal payments would be due until April 30, 2008"

Tennenbaum said the offer will remain open until the earlier of April 30, 2008 or the sale of PWAS to a third party.

Labels: ,

Point.360 (PTSX) Soars As Deal with DG FastChannel (DGIT) Finally Inked

Shareholders of Point.360 (Nasdaq: PTSX), a stock we've been tracking, were rewarded today after DG FastChannel, Inc. (Nasdaq: DGIT) entered into an agreement whereby (i) Point.360 will spin off its post production operations to Point.360 stockholders and (ii) DG FastChannel will acquire Point.360's Ads distribution operations.

We first noted DG FastChannel's position in Point.360 on December 28, 2006 after the company acquired a large stake from Point.360 shareholder Midwood Capital. We also updated the developments in several follow-up reports. DG FastChannel was aggressively raising its stake in Point.360 which stirred rumors of a buyout.

Shares of Point.360 are up 40% today to $5.18 on the news.

Labels: , , ,

Monday, April 16, 2007

Saudi Billionaire Maan Al-Sanea Shows 3.11% Stake in HSBC (HBC)


Not an activist situation, but interesting:

Saudi billionaire Maan Abdulwahed Al-Sanea, through this Singularis Holdings Ltd subsidiary, disclosed a 3.11% stake in HSBC Holdings (NYSE: HBC). Al-Sanea showed indirect holdings of 360,055,575 shares.

Forbes lists Maan Al-Sanea as No. 97 on the list of the world's billionaires with an estimated net worth of $7.5 billion, making his money mainly from construction.

Labels: , ,

Third Avenue Management Changes Filing Status on Handleman (HDL) to 13D, Notes 15.6% Stake

In a 13D filing Friday on Handleman Co. (NYSE: HDL), 15.6% holder (3.16 million shares) Third Avenue Management LLC noted they changed their filing status from 13G (passive) to 13D (active). Third Avenue Management held 3.02 million shares of HDL at the quarter ended December 31, 2006.

In a pretty standard disclosure, Third Avenue Management said they may seek to meet with the board of directors and/or members of senior management or communicate publicly or privately with other stockholders or third parties to indicate its views on issues relating to the strategic direction undertaken by the Issuer and other matters of interest to stockholders generally. As part of any such discussions, they may suggest changes in, or take positions relating to, the strategic direction of the Issuer as a means of enhancing shareholder value.

Labels: , ,

Dissident Laureate Education (LAUR) Holder Select Equity Group Raises Stake to 9.82%

In an amended 13D filing Friday on Laureate Education, Inc. (Nasdaq: LAUR), Select Equity Group disclosed a 9.82% stake (5.05 million shares) in the company. This is up from the 7.14% stake (3.7 million shares) the firm disclosed in the original February 13D filing.

In the original 13D filing, the firm disclosed a letter sent to the Board of Directors expressing their reservations about the management-led buyout transaction at $60.50 per share. The firm said the stock is worth "substantially more".

Another large Laureate Education, T. Rowe Price, has also come out against the deal.

Labels: , ,

Atmel (ATML) Founder Perlegos Files Proxy Seeking To Replace 5 Board Members

Atmel Corporation (Nasdaq: ATML) founder, former Chairman/CEO and 5.3% holder, George Perlegos, filed a definitive proxy statement with the SEC in connection with his planned solicitation of proxies at a Special Meeting of Shareholders scheduled for May 18, 2007 for Atmel shareholders of record as of April 5, 2007. Mr. Perlegos is seeking support from fellow Atmel shareholders to elect five nominees at the Special Meeting to replace five members of Atmel's current Board of Directors. If his five nominees are elected, they would seek to add an three additional seats.

The definitive proxy statement filed today outlines a plan to drive shareholder value at Atmel, including divesting non-core assets to make Atmel a pure-play microcontroller company, hiring an experienced, new President and CEO, and initiating a $500 million to $1 billion share repurchase program.

Labels: , ,

Icahn No Longer Intends to Nominate an Opposing MedImmune (MEDI) Board

Carl Icahn said now that MedImmune's (Nasdaq: MEDI) board has announced it intends to sell the company, he no longer intends to put forth an opposition slate. Icahn said he will closely monitoring the Company's efforts and reserves the right to launch a proxy contest in the event that MedImmune does not successfully complete the sale transaction.

Several weeks ago Icahn informed the company he believed the best course of action was to put the company up for sale and planed to nominate an opposing slate at the upcoming 2007 annual meeting.

Labels: , ,

Friday, April 13, 2007

Large Las Vegas Home Builder Accumulates a 7% Stake in Dominion Homes (DHOM), Stock Higher

In a 13D filing after the close on Dominion Homes Inc. (Nasdaq: DHOM), James Michael Rhodes disclosed a 7.06% stake (594K shares) in the company.

James M. Rhodes is as President and Chief Executive Officer of Sagebrush Enterprises, Inc., which is in the principal business of developing residential communities and homebuilding in southern Nevada and Arizona. Sagebrush Enterprises is affililated with Rhodes Homes.

According Rhodes Homes' website, Rhodes Homes has established itself as the largest independent homebuilders in Las Vegas and Nevada. Link

Dominion Homes builds a variety of new homes and condominiums in Columbus, Ohio and Louisville and Lexington, Kentucky.

Shaeres of Dominion Homes are up 13% today.

Labels: , ,

Icahn Solicits Votes For Motorola (MOT) Board Seat, Says Buy-Backs and Other Transactions Need a Back Seat

Carl Icahn issues a letter soliciting Motorola, Inc. (NYSE: MOT) shareholders to elect him to the company's board of directors.

In the letter Icahn said, "My experience tells me that Motorola's problems reflect not only operational failures, but are also symptoms of a passive and reactive Board."

He also said, "Clearly our Board members' top priority should be to hold management accountable for fixing Motorola's current operational problems -- and if I am elected to the Board I will do so. Until our operational problems are corrected, buy-backs and other transactions that might have looked appropriate earlier need to take a back seat. Otherwise I come to Motorola with no preconceived notions."


Icahn and his affiliates currently own over 68 million shares of Motorola common stock.

A Copy of the Letter:


Dear Fellow Motorola Shareholder:

THE ENCLOSED PROXY STATEMENT SOLICITS YOUR VOTE TO ELECT ME TO THE BOARD OF DIRECTORS OF OUR COMPANY. I have long asserted that shareholders must have a strong voice on corporate boards. I would like to serve as a Motorola Board member for all of our benefit -- and I can do it with your support!

My affiliates and I currently own over 68 million shares of Motorola common stock. We believe in the Company's great potential. I had hoped that the existing Board would have simply added me as a new member without the distraction of a proxy fight. However, I am willing to expend the time, effort and money necessary to seek election through this proxy contest so that all ofus will have a shareholder voice on the Motorola Board. I fail to understand why, during these difficult times when they could obviously potentially benefit from a fresh perspective, Motorola refuses to put me, a large shareholder with significant business experience, on the Board.

I am concerned, as I know many of you are, with certain recent events at Motorola, such as the surprise fourth-quarter drop in earnings for its Mobile Devices segment and the recently announced expectations for disappointing results throughout 2007. In my view, an engaged Board of Directors should have been able to help Motorola avoid the missteps that currently plague its business, or at least to have identified and addressed those problems earlier.My experience tells me that Motorola's problems reflect not only operational failures, but are also symptoms of a passive and reactive Board. Clearly our Board members' top priority should be to hold management accountable for fixing Motorola's current operational problems -- and if I am elected to the Board I will do so. Until our operational problems are corrected, buy-backs and other transactions that might have looked appropriate earlier need to take a backseat. Otherwise I come to Motorola with no preconceived notions.

I think that I can make a positive difference at Motorola. I will bring a set of experiences and perspective that will be additive to the Board, based upon the nearly 40 years that I have spent analyzing, owning and running companies.Furthermore, unlike the existing directors, I have made a substantial investment in Motorola and, consistent with my business philosophy that large investors make the best Board members, I believe that the alignment of my interests with those of the Company and its shareholders make me uniquely suited for this position. In my career I have been successful in businesses in industries as diverse as telecom, automotive, oil and gas, gaming, real estate and biotechnology, among others and shareholders have benefited from those successes. BUSINESS JUDGMENT AND EXPERIENCE ARE THE CRITICAL TRAITS FOR ANY MOTOROLA DIRECTOR IN THE CHALLENGING TIMES THAT LIE AHEAD -- TRAITS THAT I CLEARLY WILL BRING TO THE MOTOROLA BOARDROOM. Although I do sit on a number of boards, I expect to commit the time to Motorola that is commensurate with my large investment and the responsibility that this new position brings with it.Therefore, if I am elected I will reduce my membership on the boards of public companies to less than six.

I expect, as has been the case with other boards on which I have served, to have a good working relationship with my fellow Motorola Board members and with management. But I do view it as a working relationship, not a social one. I believe that my role as a Board member is to make sure that the Board is well aware of what is going on at the Company, to ask the tough questions and require that they be fully answered, to speak out before problems manifest themselves(such as those that Motorola is now trying to work its way out of), and to hold management to a high standard of excellence. My biggest concern for Motorola is that Board members may wait too long to speak up in the face of continued operational failures, allowing our Company to slip into a steep decline. I assure you with me as a Board member that would never happen.

It is my desire to be an active, constructive Board member and to help guide Motorola through its current difficulties so that it can achieve its full potential. If you agree with me that the best way to protect our interests at Motorola is to add a large shareholder, independent of management, to the Motorola Board, then please give me your support by voting FOR on the enclosed GOLD proxy card today.

Sincerely,

Carl C. Icahn

Labels: , ,

Thursday, April 12, 2007

Comverse Tech (CMVT) Holder Oliver Press Partners Seeks To Call Special Meeting and Elect New Directors

Yesterday afternoon, Oliver Press Partners filed a solicitation statement saying they intend to seek support from fellow Comverse Technology (OTC: CMVT) shareholders having at least ten percent (10%) of Comverse's common stock for the purpose of calling a special meeting to elect directors. Oliver Press Partners said Comverse has failed to hold an annual meeting of shareholders since June 16, 2005.

Oliver Press Partners said they intend to nominate principals Augustus K. Oliver and Clifford Press, for election to the Board along with the Company's current directors assuming they consent.
If elected, Messrs. Oliver and Press intend to encourage the full Board to direct an investment banking firm to work with Comverse's counsel and auditors to develop a value recovery plan for Comverse that can be implemented promptly once Comverse is current in its filing and other requirements under applicable securities regulations.
Clifford Press, a partner in Oliver Press Partners , said, "We have been discussing with members of Comverse's Board the need for shareholder participation since early February, but no action has been taken by them to date. Our corporate law has long recognized that public company boards can not and should not be able to perpetuate themselves in office by simply failing to call and hold a shareholder meeting. It is now twenty two months since shareholders have had any say in who is overseeing their Comverse investment. We believe that shareholders both desire and deserve that say today."
In the SEC filing, Oliver Press Partners noted they began purchasing shares on the company in mid-November and accumulated most of the shares now owned in late November and early December.
Oliver Press Partners has not filed a 13D, indicating they do not have a 5% or more stake in CMVT currently.

Labels: , ,

Nierenberg Happy Again With Electro Scientific (ESIO), Backs Off Replacing Board

In an amended 13D filing on Electro Scientific Industries Inc. (Nasdaq: ESIO), 11.8% holder Nierenberg Investment Management said it is pleased that the company booked strong Q3 orders and approved a $50 million share repurchase program. The firm said, at present, they do not anticipate nominating their own alternate board candidates, as they had previously threatened.

Nierenberg said, "We are pleased with ESIO's announcement on April 10 that it booked strong orders in its third fiscal quarter and that its board approved a $50 million share repurchase program. We expressed our enthusiasm for these developments during the company's conference call.

The concerns which we had expressed in our prior 13D amendment related to ESIO's balance sheet management, financial strategy, and investor communications. ESIO's announcements on April 10 were responsive to our concerns. Though the initial size of the company's share repurchase program is smaller than we had proposed, we recognize the deliberation which has gone into the board's decision, appreciate the change in their direction, and view their initial commitment as tangible and substantial. As we said during the conference call, we view ESIO's commitment to repurchasing shares as being shareholder-friendly and accretive. We hope and trust that the program will be carried out effectively and expeditiously and that it will have the intended impact on ESIO's return on equity. Evidently ESIO's board anticipates this as well. If our thinking proves right, then we also hope that the company will continue with an enlarged and ongoing share repurchase program in the future.

As we have said before, we have been patient, supportive, and constructive shareholders of ESIO for a long time. The company's April 10 announcement has refreshed our patience. As long term investors, we are now prepared to wait and watch the company's performance. We recognize that boosting ROE into the mid-teens, through repurchases and improving operating performance, will taketime. At present, we do not anticipate nominating our own alternate board candidates at the company's 2007 annual shareholder meeting."

Labels: , ,

Icahn's Golden Touch Finds MedImmune (MEDI)

Carl Icahn has the golden touch.

This morning, another one of his target companies, MedImmune, Inc. (Nasdaq: MEDI), said they hired Goldman Sachs to explore strategic alternatives, sending the stock up 12%.
The company said, "indications of interest by major pharmaceutical companies, coupled with recent expressions by certain stockholders of dissatisfaction with the company's short-term stock price performance, have led the board to authorize management to gather information regarding possible strategic interest in acquiring the company."

In its latest 13F, Carl Icahn's Icahn Management noted they built up a 2.775 million shares stake (1.2%) in MEDI.

Labels: , ,

Whitworth's Relational Investors Now Targeting Sprint-Nextel (S)

According to reports from the Wall Street Journal, activist investor Relational Investors has built a stake of about $500 million, or nearly 1%, in Sprint-Nextel (NYSE: S).

The paper said Relational Investors' Ralph Whitworth has been calling for a number of changes at the company, including a pullback in its capital spending and a potential sale of its fiber-optic networking and long-distance operation.

On Tuesday, Relational Investors said they sold their remaining shares in Ceridian Corp. (NYSE: CEN), with Whitworth saying the firm has "bigger fish to fry."

Relational Investors was recently successful in its push to remove Home Depot (NYSE: HD) CEO Bob Nardelli and to split off the HD Supply business. Relational Investors was also provided a seat on Home Depot's board.

Past reports on Relational Investors

Labels: , , ,

Wednesday, April 11, 2007

Loeb's Wants PDLI's CEO's Head; Says Co Turned Away $30 Bid

Dan Loeb's Third Point LLC demands that PDL BioPharma's (Nasdaq: PDLI) CEO Mark McDade be terminated or resign.

In a letter to the company the firm said that. "We believe that a PDLI unencumbered by Mr. McDade's management blunders and wasteful spending will appreciate in value considerably, and thus we have increased our position by 1,100,000 shares and now beneficially own 9.7% of the Company's outstanding stock."

Loeb also said, "There is no better example of McDade's "empire building" philosophy, pathological selfishness and poor business judgment than his decision to build out PDLI's absurdly large and unnecessary new corporate headquarters (the "Taj Mahal"). It is appalling that Mr. McDade is spending nearly $100 million of our money to build out 450,000 square feet of leased space, much of which is completely unnecessary." Loeb said dedicated PDLI employees are to be significantly inconvenienced by the move, while it is close to McDade's home.

Loeb also said, "We also learned from sources we deem to be reliable that PDLI received a takeover bid from a large pharmaceutical company for more than $30 per share (approximately 50% above the current stock price), which Mr. McDade effectively dismissed out of hand as being grossly insufficient."

Loeb also said, "we believe that the Company should examine splitting into two publicly traded entities - one a commercial operation, and the other an R&D company"

Loeb said, " we would note that we have spoken with many business development directors from major and mid-sized pharmaceutical and biotechnology companies, and the consistent feedback is that Third Point is correct in its analysis of PDLI - that it is a poorly-managed company with substantial assets." One comment Loeb heard and quoted was, "McDade acts and spends like he runs a big pharma company, but he has none of the infrastructure, assets or managerial ability."

A Copy of the Letter:

Dear Mr. McDade and PDL BioPharma Board Members:

In our initial letter to you dated March 5, 2007, we expressed a sincere and strong interest, as PDL BioPharma's ("PDLI" or the "Company") largest shareholder, to work constructively and discreetly with management and the Board of Directors to implement the cost-cutting and other measures necessary to fully enhance the extraordinary value inherent within PDLI that is currently being obscured by the Company's equally extraordinary current levels of spending. Indeed, we are certain that you are aware that our initial overtures have been greeted by overwhelming shareholder support and positive Wall Street research reports. The Company's shares have also reacted positively, rising 15%, or increasing in value by over $300mm, as a result of our involvement - to the benefit of all shareholders. After our first telephone calls with management in March, we were hopeful that matters were moving in the right direction, as they agreed to retain either the leading consulting firm that we proposed, or one of similar stature, to analyze your excessive R&D and SG&A spending, and to seriously consider our highly- qualified nominees to the PDLI Board of Directors.

Unfortunately, our initial optimism that we could work constructively with management quickly faded through a series of subsequent telephone calls with Mr. McDade, culminating in a "slap-in-the face" on Friday, April 6th, in which it became abundantly clear that Mr. McDade has no intention of pursuing a constructive dialogue. It became apparent that the earlier dialogue was a charade intended to stall for time, a tactic we have seen employed many times before by underperforming CEOs. Mr. McDade's inexplicable insouciance towards us, along with numerous negative findings that emerged over the course of our ongoing investigation (the "Investigation") into Mr. McDade's managerial abilities, judgment and ethics (discussed below), led us to determine that it is in our best interests, and those of all shareholders, to terminate discussions with Mr. McDade.

Many fund managers who have been similarly rebuffed, and who have detected such a deficit in talent, probity and judgment as we have come to find in Mr. McDade, might come to the logical conclusion to "cut and run" and decrease their positions as one major mutual fund has done according to recent filings. Instead, we have come to a different view: we concluded that the Board of Directors has no choice but to immediately terminate Mr. McDade. We believe that a PDLI unencumbered by Mr. McDade's management blunders and wasteful spending will appreciate in value considerably, and thus we have increased our position by 1,100,000 shares and now beneficially own 9.7% of the Company's outstanding stock.

In support of our demands for Mr. McDade's immediate termination, we review below the content of our discussions and negotiations over the past month and elaborate on the specific significant mismanagement and waste for which Mr. McDade is directly culpable.

McDade's Insincerity and Disorganization

During the past month we had four separate calls with Mr. McDade in which we repeatedly expressed our concerns regarding spending levels and other planned strategic initiatives by the Company. In each call, we reiterated our interest in working with him and with the Board in order to better understand and rationalize the cost structure at PDLI and to help realize the many valuable, currently poorly-recognized assets embedded within the Company. From the very first conversation, we made it clear that, as PDLI's largest shareholder by a wide margin, Board representation would be essential, and we submitted to Mr. McDade the names of four highly-qualified candidates for consideration. On March 30th, Mr. McDade informed us that none of our four candidates fits the profile of what PDLI is looking for in a Board member, but that the Board would (reluctantly) consider one of our candidates. We replied that this was not acceptable, and demanded that two of the other three candidates be named to the Board. At our suggestion, and in response to his now obviously feigned interest, we provided to Mr. McDade that very afternoon the contact information for TWELVE references for our Board candidates - all of them senior management or Board members of public companies with whom we've worked (and, in most cases, served on boards with). Mr. McDade and his assistant sent follow-up emails with questions regarding the references list. However, when we spoke with Mr. McDade again this past Friday, he informed us that none of our candidates is "qualified" to serve on PDLI's board. Although Mr. McDade is dead wrong about this, what is truly galling, and what speaks directly to Mr. McDade's lack of character, professionalism, and competence, is that our references reported to us that Mr. McDade did not call a single one of them to hear first-hand about the tremendous value that our candidates have brought to shareholders by working on other public boards, both within and outside of the biotechnology arena.

Moreover, one of our director candidates, Mr. Jason Aryeh, emailed to Mr. McDade contact information for his references, followed up with a confirmatory call to Mr. McDade's assistant Diana, and sent a second email to ensure its receipt. Nonetheless, Mr. McDade claimed days later never to have seen this important correspondence so essential to evaluating our candidates' qualifications to join the PDLI board, and even then he did nothing with the information it contained (despite assurances to the contrary). How can Mr. McDade purport to effectively run a public biotechnology company with a market capitalization of over $2 billion when he cannot even manage his own Microsoft Outlook inbox?

It is now clear to us that we've wasted the last month attempting to engage in a productive dialogue with Mr. McDade, while his only objective was to buy himself more time. We've been engaged in discussions with the Company for over a year about our concerns, and have heard management's explanations and excuses countless times over that entire period. The unfortunate truth is that so long as Mr. McDade remains CEO, which we expect will not be much longer, the Company will have no intention of doing the "right thing" by scaling back SG&A and R&D spending to economically justifiable levels.

We also want to emphasize that during the course of our discussions over the past month it became clear that Mr. McDade does not see the benefits of adding representatives of the major owners of the Company to the Board. In fact, he told us that the Board's ideal next candidate(s) would be a late- stage development expert. We have explained to Mr. McDade why adding shareholder representatives is vital at this point, as management is demonstrably not effectively telling the PDLI story to the world - as evidenced by the major disconnect between the current stock price of PDLI and the much higher inherent asset value of the Company. Additionally, it is obvious that PDLI needs to understand the investment community's perspective regarding the Company's economically unjustifiable spending. On this point, as noted earlier, we are pleased that the Company has agreed to hire a major consulting firm immediately to undertake the critical analysis of all of the Company's current and planned SG&A and R&D spending, with the goal of materially cutting back on both if they are deemed to be economically imprudent.

McDade's Taj Mahal - Massive Waste, a Shorter Commute for McDade and a Slip for his Yacht, but a Longer Commute for Employees

There is no better example of McDade's "empire building" philosophy, pathological selfishness and poor business judgment than his decision to build out PDLI's absurdly large and unnecessary new corporate headquarters (the "Taj Mahal"). It is appalling that Mr. McDade is spending nearly $100 million of our money to build out 450,000 square feet of leased space, much of which is completely unnecessary. But what is most troubling is what this says about his overall business judgment and qualification to continue to run the Company. As examples:

* Mr. McDade decided to lease, and build out, the Taj Mahal (reportedly the largest corporate lease deal, as measured in square footage, signed in the Bay Area in 2006) despite the fact that members of PDLI's financial team reportedly advised him that the expenditures were both unnecessary and imprudent;

* Mr. McDade has, from the beginning of this project, apparently been fixated on when his boat slip in the marina adjacent to the new corporate headquarters will be ready (one would think that the CEO of a Company, the stock price of which was down 40% last year - and the second worst performer in the entire biotechnology index - would have more important priorities), and

* Mr. McDade has made it clear in private that one of the key drivers behind his decision to relocate the Company from Fremont to Redwood City is that the new headquarters location will lead to a far shorter commute to work for him from his home in Woodside (not only less than one-half the mileage, but he will not have to cross any heavily-trafficked Bay bridges to get to the new headquarters). For those unfamiliar with the geography, below is a map detailing the pertinent locations:

(Photo: http://www.newscom.com/cgi-bin/prnh/20070411/NYW097)

Although the propinquity of the Taj Mahal to McDade's home is convenient for PDLI's imperial CEO, scores of current dedicated PDLI employees are to be significantly inconvenienced by the move. This issue was so significant that the Company's attorneys felt that it was an issue that merited disclosure in the risk section of PDLI's 2006 10-K:


We believe that the move of our corporate headquarters from Fremont, California to Redwood City, California, in the second half of 2007, may before and for a period after the move cause employee turnover to increase and make retaining key employees more difficult because our new headquarters is 12 miles away from our current headquarters and on the other side of the San Francisco Bay, which will increase the commute time of the many employees that reside in and around Fremont, California and the greater East Bay Area of the San Francisco Bay area.

Premium Offer Rebuffed? ... Strategic Alternatives Should be Reviewed Immediately

We also learned from sources we deem to be reliable that PDLI received a takeover bid from a large pharmaceutical company for more than $30 per share (approximately 50% above the current stock price), which Mr. McDade effectively dismissed out of hand as being grossly insufficient. While we share the view that PDLI is significantly undervalued, we believe that due care requires management to present all such expressions of interest to the Board. We are not necessarily advocating a sale of the Company at this time (although it should be carefully considered), but we believe that if such bidding interest exists, it should be carefully weighed against the present value of the Company in a scenario where it executes its long term operating plan under new, better-qualified management.

In addition, we believe that the Company should examine splitting into two publicly traded entities - one a commercial operation, and the other an R&D company. We believe that material incremental value could be created through such a separation and have raised this concept with Mr. McDade (not surprisingly, given his empire-building mindset, he had not given this structure a thought previously, and laughed dismissively - or perhaps defensively - when we suggested it). We would be happy to share with the Board our analysis as to why we believe that separating PDLI into two public companies would create significant shareholder value. Finally, we firmly believe that any deals currently being contemplated to encumber Ularitide, or to commit the Company to further R&D spending on this product, should be suspended while the above analyses are ongoing.

In Monday's press release announcing Max Link's resignation from the Board, Mr. McDade again referred to "continuing to build stockholder value by leveraging our antibody platform ...." Perhaps Mr. McDade uses a different, more favorable, group of stock charts than we do, but ours show that PDLI was down 40% last year; was flat in the three years from 2004 to 2006 while the biotech index gained 50% (and the stocks of PDLI's partners flourished); and, by the way, is only up this year because the market has reacted favorably to Third Point's involvement.

We are confident that we have the support of a majority of PDLI's shareholders, and clearly have the support of a large number of sell-side research analysts. Indeed, Prudential upgraded PDLI from a hold to a buy on March 25th in a report headlined "Calls for Strategic Changes Increasing; Could Spark Stock Rally if Implemented." Prudential's report then went on to say:

The public pressure being applied by Third Point could lead to positive dramatic changes in the company. The primary reason for our change of heart is that we believe some drastic measures would have to be taken to transform this company from a slow moving, yet costly specialty/biotech company to a more focused biotech company that can deliver returns that match investors' expectations.

On that same day Merrill Lynch wrote a positive report entitled "Does Third Point have a point?" - with the answer being a resounding "yes."

Lastly we would note that we have spoken with many business development directors from major and mid-sized pharmaceutical and biotechnology companies, and the consistent feedback is that Third Point is correct in its analysis of PDLI - that it is a poorly-managed company with substantial assets. A few comments we heard from this well-respected and knowledgeable group include:

McDade acts and spends like he runs a big pharma company, but he has none of the infrastructure, assets or managerial ability.

PDLI has enviable assets, but they will never get the benefit of them with McDade running the Company. He needs to be thrown out immediately.

He has consistently disappointed the Street by missing revenue and earnings projections and development timelines. Why will it be any different going forward?

What PDLI needs is financial discipline and new management.

Needless to say, we agree wholeheartedly with these opinions. We are confident that some members of PDLI's Board share our negative sentiment towards Mr. McDade. We urge these members to speak up and take action to dismiss him immediately. Indeed, we believe that there are several Board members who are far more capable that Mr. McDade of managing PDLI properly and would ask that they volunteer to serve as interim-CEO at a minimum, while the Company reassess its spending plans and analyzes all options to maximize value for PDLI's shareholders.

When Mr. McDade became CEO in 2002, he made a pledge to create shareholder value. Nearly five years later he has not lived up to his pledge. It is now time to put the valuable assets of this Company into more capable hands, either by bringing in a high-quality CEO or selling the assets to a larger, better-run company, before the Company's asset values are further diminished by uncontrolled and wasteful spending under his ineffective stewardship. Mr. McDade has said repeatedly that he serves at the will of shareholders, and would immediately step down if shareholders do not want him running the Company anymore. It is clear to us that a majority of PDLI's shareholders share our views, so we therefore demand that Mr. McDade stop hiding behind the Company's corporate defenses and newly-instituted poison pill and live up to his word by resigning. (We believe that we can deliver consents from a majority of the Company's shareholders calling for Mr. McDade's resignation to prove our point.) Also, we have high regard for the professional scientific personnel at PDLI, and the scientific accomplishments of many PDLI Board members, and believe that the languishing share price deprives them of opportunities to be appropriately rewarded for their efforts.

We would be pleased to speak directly with the Board, once Mr. McDade is terminated, to work together constructively to achieve our goal, and your fiduciary duty, to run the Company properly in order to create maximum value at PDLI for all stakeholders.

Sincerely,
Daniel S. Loeb
Chief Executive Officer

Labels: , , ,